Industry: Medical Devices & Consumables
Published Date: 2025-09-10
Pages: 97 Pages
Report ld: 4931232
Request Sample
Customized Report
Transcranial Magnetic Stimulators (TMS) Market Size(US$)

CAGR 2025-2031
16.0%
Market Size,2031
USD 512
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Transcranial Magnetic Stimulators (TMS) market size was US$ 184 million in 2024 and is forecast to a readjusted size of US$ 512 million by 2031 with a CAGR of 16.0% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Transcranial Magnetic Stimulators (TMS) market competitiveness, regional economic performance, and supply chain configurations.
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
A key driver of the transcranial magnetic stimulator (TMS) market is the rising prevalence of mental health disorders, particularly treatment-resistant depression and anxiety. As traditional therapies like medication and psychotherapy prove ineffective for some patients, there is increasing demand for alternative, non-invasive treatment options such as TMS. Additionally, growing awareness of TMS as a safe and effective intervention, coupled with technological advancements that improve its accessibility and precision, is driving market growth. A major challenge in the TMS market is the high cost of equipment and treatment sessions, which can limit accessibility for both healthcare providers and patients. TMS devices are expensive, and the treatments often require multiple sessions, making it a costly option for patients, particularly those without insurance coverage. Furthermore, limited awareness and availability of TMS in certain regions, as well as the need for trained professionals to administer the treatment, can create additional barriers to market expansion.
Global key players of transcranial magnetic stimulators (TMS) include Yiruide, Magstim, Neuronetics, etc. China is the largest producer of fNIRS brain imaging system, holds a share about 40%, followed by North America, and Europe. In terms of product, rTMS is the largest segment, with a share over 55%. And in terms of application, the largest segment is psychopharmacology, with a share over 45%.
The global Transcranial Magnetic Stimulators (TMS) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Transcranial Magnetic Stimulators (TMS) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., sTMS in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Neurology in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Transcranial Magnetic Stimulators (TMS) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Transcranial Magnetic Stimulators (TMS) Product Scope
1.2 Transcranial Magnetic Stimulators (TMS) by Type
1.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Type (2020 & 2024 & 2031)
1.2.2 rTMS
1.2.3 sTMS
1.2.4 pTMS
1.2.5 Others
1.3 Transcranial Magnetic Stimulators (TMS) by Application
1.3.1 Global Transcranial Magnetic Stimulators (TMS) Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Psychopharmacology
1.3.3 Neurology
1.3.4 Rehabilitation Department
1.3.5 Others
1.4 Global Transcranial Magnetic Stimulators (TMS) Market Estimates and Forecasts (2020-2031)
1.4.1 Global Transcranial Magnetic Stimulators (TMS) Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Transcranial Magnetic Stimulators (TMS) Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Transcranial Magnetic Stimulators (TMS) Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Transcranial Magnetic Stimulators (TMS) Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Transcranial Magnetic Stimulators (TMS) Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales Market Share by Region (2020-2025)
2.2.2 Global Transcranial Magnetic Stimulators (TMS) Revenue Market Share by Region (2020-2025)
2.3 Global Transcranial Magnetic Stimulators (TMS) Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Transcranial Magnetic Stimulators (TMS) Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Transcranial Magnetic Stimulators (TMS) Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Transcranial Magnetic Stimulators (TMS) Market Size and Prospective (2020-2031)
2.4.2 Europe Transcranial Magnetic Stimulators (TMS) Market Size and Prospective (2020-2031)
2.4.3 China Transcranial Magnetic Stimulators (TMS) Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Transcranial Magnetic Stimulators (TMS) Historic Market Review by Type (2020-2025)
3.1.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Type (2020-2025)
3.1.2 Global Transcranial Magnetic Stimulators (TMS) Revenue by Type (2020-2025)
3.1.3 Global Transcranial Magnetic Stimulators (TMS) Price by Type (2020-2025)
3.2 Global Transcranial Magnetic Stimulators (TMS) Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales Forecast by Type (2026-2031)
3.2.2 Global Transcranial Magnetic Stimulators (TMS) Revenue Forecast by Type (2026-2031)
3.2.3 Global Transcranial Magnetic Stimulators (TMS) Price Forecast by Type (2026-2031)
3.3 Different Types Transcranial Magnetic Stimulators (TMS) Representative Players
4 Global Market Size by Application
4.1 Global Transcranial Magnetic Stimulators (TMS) Historic Market Review by Application (2020-2025)
4.1.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Application (2020-2025)
4.1.2 Global Transcranial Magnetic Stimulators (TMS) Revenue by Application (2020-2025)
4.1.3 Global Transcranial Magnetic Stimulators (TMS) Price by Application (2020-2025)
4.2 Global Transcranial Magnetic Stimulators (TMS) Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales Forecast by Application (2026-2031)
4.2.2 Global Transcranial Magnetic Stimulators (TMS) Revenue Forecast by Application (2026-2031)
4.2.3 Global Transcranial Magnetic Stimulators (TMS) Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Transcranial Magnetic Stimulators (TMS) Application
5 Competition Landscape by Players
5.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Players (2020-2025)
5.2 Global Top Transcranial Magnetic Stimulators (TMS) Players by Revenue (2020-2025)
5.3 Global Transcranial Magnetic Stimulators (TMS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcranial Magnetic Stimulators (TMS) as of 2024)
5.4 Global Transcranial Magnetic Stimulators (TMS) Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Transcranial Magnetic Stimulators (TMS), Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Transcranial Magnetic Stimulators (TMS), Product Type & Application
5.7 Global Key Manufacturers of Transcranial Magnetic Stimulators (TMS), Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Transcranial Magnetic Stimulators (TMS) Sales by Company
6.1.1.1 North America Transcranial Magnetic Stimulators (TMS) Sales by Company (2020-2025)
6.1.1.2 North America Transcranial Magnetic Stimulators (TMS) Revenue by Company (2020-2025)
6.1.2 North America Transcranial Magnetic Stimulators (TMS) Sales Breakdown by Type (2020-2025)
6.1.3 North America Transcranial Magnetic Stimulators (TMS) Sales Breakdown by Application (2020-2025)
6.1.4 North America Transcranial Magnetic Stimulators (TMS) Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Transcranial Magnetic Stimulators (TMS) Sales by Company
6.2.1.1 Europe Transcranial Magnetic Stimulators (TMS) Sales by Company (2020-2025)
6.2.1.2 Europe Transcranial Magnetic Stimulators (TMS) Revenue by Company (2020-2025)
6.2.2 Europe Transcranial Magnetic Stimulators (TMS) Sales Breakdown by Type (2020-2025)
6.2.3 Europe Transcranial Magnetic Stimulators (TMS) Sales Breakdown by Application (2020-2025)
6.2.4 Europe Transcranial Magnetic Stimulators (TMS) Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Transcranial Magnetic Stimulators (TMS) Sales by Company
6.3.1.1 China Transcranial Magnetic Stimulators (TMS) Sales by Company (2020-2025)
6.3.1.2 China Transcranial Magnetic Stimulators (TMS) Revenue by Company (2020-2025)
6.3.2 China Transcranial Magnetic Stimulators (TMS) Sales Breakdown by Type (2020-2025)
6.3.3 China Transcranial Magnetic Stimulators (TMS) Sales Breakdown by Application (2020-2025)
6.3.4 China Transcranial Magnetic Stimulators (TMS) Major Customer
6.3.5 China Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Yiruide
7.1.1 Yiruide Company Information
7.1.2 Yiruide Business Overview
7.1.3 Yiruide Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Yiruide Transcranial Magnetic Stimulators (TMS) Products Offered
7.1.5 Yiruide Recent Development
7.2 Neuronetics
7.2.1 Neuronetics Company Information
7.2.2 Neuronetics Business Overview
7.2.3 Neuronetics Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Neuronetics Transcranial Magnetic Stimulators (TMS) Products Offered
7.2.5 Neuronetics Recent Development
7.3 Magstim
7.3.1 Magstim Company Information
7.3.2 Magstim Business Overview
7.3.3 Magstim Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Magstim Transcranial Magnetic Stimulators (TMS) Products Offered
7.3.5 Magstim Recent Development
7.4 MagVenture
7.4.1 MagVenture Company Information
7.4.2 MagVenture Business Overview
7.4.3 MagVenture Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.4.4 MagVenture Transcranial Magnetic Stimulators (TMS) Products Offered
7.4.5 MagVenture Recent Development
7.5 Neurosoft
7.5.1 Neurosoft Company Information
7.5.2 Neurosoft Business Overview
7.5.3 Neurosoft Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Neurosoft Transcranial Magnetic Stimulators (TMS) Products Offered
7.5.5 Neurosoft Recent Development
7.6 Brainsway
7.6.1 Brainsway Company Information
7.6.2 Brainsway Business Overview
7.6.3 Brainsway Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Brainsway Transcranial Magnetic Stimulators (TMS) Products Offered
7.6.5 Brainsway Recent Development
7.7 eNeura
7.7.1 eNeura Company Information
7.7.2 eNeura Business Overview
7.7.3 eNeura Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.7.4 eNeura Transcranial Magnetic Stimulators (TMS) Products Offered
7.7.5 eNeura Recent Development
7.8 Remed
7.8.1 Remed Company Information
7.8.2 Remed Business Overview
7.8.3 Remed Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Remed Transcranial Magnetic Stimulators (TMS) Products Offered
7.8.5 Remed Recent Development
7.9 Nexstim
7.9.1 Nexstim Company Information
7.9.2 Nexstim Business Overview
7.9.3 Nexstim Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Nexstim Transcranial Magnetic Stimulators (TMS) Products Offered
7.9.5 Nexstim Recent Development
7.10 MAG & More
7.10.1 MAG & More Company Information
7.10.2 MAG & More Business Overview
7.10.3 MAG & More Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.10.4 MAG & More Transcranial Magnetic Stimulators (TMS) Products Offered
7.10.5 MAG & More Recent Development
7.11 Jiangxi Brain Modulate
7.11.1 Jiangxi Brain Modulate Company Information
7.11.2 Jiangxi Brain Modulate Business Overview
7.11.3 Jiangxi Brain Modulate Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Jiangxi Brain Modulate Transcranial Magnetic Stimulators (TMS) Products Offered
7.11.5 Jiangxi Brain Modulate Recent Development
7.12 VISHEE
7.12.1 VISHEE Company Information
7.12.2 VISHEE Business Overview
7.12.3 VISHEE Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.12.4 VISHEE Transcranial Magnetic Stimulators (TMS) Products Offered
7.12.5 VISHEE Recent Development
7.13 YINGCHI
7.13.1 YINGCHI Company Information
7.13.2 YINGCHI Business Overview
7.13.3 YINGCHI Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.13.4 YINGCHI Transcranial Magnetic Stimulators (TMS) Products Offered
7.13.5 YINGCHI Recent Development
7.14 Junjian Wanfeng
7.14.1 Junjian Wanfeng Company Information
7.14.2 Junjian Wanfeng Business Overview
7.14.3 Junjian Wanfeng Transcranial Magnetic Stimulators (TMS) Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Junjian Wanfeng Transcranial Magnetic Stimulators (TMS) Products Offered
7.14.5 Junjian Wanfeng Recent Development
8 Transcranial Magnetic Stimulators (TMS) Manufacturing Cost Analysis
8.1 Transcranial Magnetic Stimulators (TMS) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Transcranial Magnetic Stimulators (TMS)
8.4 Transcranial Magnetic Stimulators (TMS) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Transcranial Magnetic Stimulators (TMS) Distributors List
9.3 Transcranial Magnetic Stimulators (TMS) Customers
10 Transcranial Magnetic Stimulators (TMS) Market Dynamics
10.1 Transcranial Magnetic Stimulators (TMS) Industry Trends
10.2 Transcranial Magnetic Stimulators (TMS) Market Drivers
10.3 Transcranial Magnetic Stimulators (TMS) Market Challenges
10.4 Transcranial Magnetic Stimulators (TMS) Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Transcranial Magnetic Stimulators (TMS) market size was US$ 210 million in 2025 and is forecast to reach a readjusted size of US$ 586 million by 2032 with a CAGR of 16.0% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 98
USD 4250.00
(Single User License)
The global Transcranial Magnetic Stimulators (TMS) market was valued at US$ 210 million in 2025 and is anticipated to reach US$ 586 million by 2032, at a CAGR of 16.0% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 124
USD 2900.00
(Single User License)
The global market for Transcranial Magnetic Stimulators (TMS) was estimated to be worth US$ 210 million in 2025 and is projected to reach US$ 586 million, growing at a CAGR of 16.0% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 112
USD 3950.00
(Single User License)
The global Transcranial Magnetic Stimulators (TMS) market is projected to grow from US$ 184 million in 2024 to US$ 512 million by 2031, at a CAGR of 16.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 167
USD 4900.00
(Single User License)
The global market for Transcranial Magnetic Stimulators (TMS) was estimated to be worth US$ 184 million in 2024 and is forecast to a readjusted size of US$ 512 million by 2031 with a CAGR of 16.0% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 129
USD 3950.00
(Single User License)
The global market for Transcranial Magnetic Stimulators (TMS) was valued at US$ 184 million in the year 2024 and is projected to reach a revised size of US$ 512 million by 2031, growing at a CAGR of 16.0% during the forecast period.
Published Date: 2025-02-07
Pages: 96
USD 2900.00
(Single User License)
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published Date: 2024-10-23
Pages: 128
USD 4350.00
(Single User License)
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published Date: 2024-10-23
Pages: 125
USD 3950.00
(Single User License)
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published Date: 2024-10-23
Pages: 146
USD 4900.00
(Single User License)
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published Date: 2024-10-23
Pages: 96
USD 2900.00
(Single User License)
The global Transcranial Magnetic Stimulators (TMS) market size was US$ 210 million in 2025 and is forecast to reach a readjusted size of US$ 586 million by 2032 with a CAGR of 16.0% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 98
The global Transcranial Magnetic Stimulators (TMS) market was valued at US$ 210 million in 2025 and is anticipated to reach US$ 586 million by 2032, at a CAGR of 16.0% from 2026 to 2032.
Published: 2026-01-05
Pages: 124
The global market for Transcranial Magnetic Stimulators (TMS) was estimated to be worth US$ 210 million in 2025 and is projected to reach US$ 586 million, growing at a CAGR of 16.0% from 2026 to 2032.
Published: 2026-01-05
Pages: 112
The global Transcranial Magnetic Stimulators (TMS) market is projected to grow from US$ 184 million in 2024 to US$ 512 million by 2031, at a CAGR of 16.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 167
The global market for Transcranial Magnetic Stimulators (TMS) was estimated to be worth US$ 184 million in 2024 and is forecast to a readjusted size of US$ 512 million by 2031 with a CAGR of 16.0% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 129
The global market for Transcranial Magnetic Stimulators (TMS) was valued at US$ 184 million in the year 2024 and is projected to reach a revised size of US$ 512 million by 2031, growing at a CAGR of 16.0% during the forecast period.
Published: 2025-02-07
Pages: 96
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published: 2024-10-23
Pages: 128
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published: 2024-10-23
Pages: 125
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published: 2024-10-23
Pages: 146
Transcranial magnetic stimulator (TMS) is a medical device that uses magnetic fields to stimulate nerve cells in the brain. This non-invasive procedure involves placing a coil near the patient's scalp, generating magnetic pulses that influence neural activity. TMS is primarily used to treat neurological and psychiatric conditions such as depression, anxiety, and certain movement disorders. It is considered a safe and effective option for patients who do not respond well to conventional treatments like medication or psychotherapy.
Published: 2024-10-23
Pages: 96
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now